Century Therapeutics Inc Cash Flow Quality Index
Latest as of March 2025:
-0.45x
Century Therapeutics Inc cash flow quality index. Century Therapeutics Inc (IPSC) has a Cash Flow Quality Index of -0.45x as of March 2025. Operating cash flow of $-34.62 Million is below net income of $76.56 Million, suggesting accrual-heavy earnings not yet converted to cash. See IPSC FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
-0.45x
Operating CF / Net Income
Operating Cash Flow
$-34.62 Million
USD
Net Income
$76.56 Million
USD
Data as of
Mar 2025
Most recent filing
Century Therapeutics Inc Cash Flow Quality Index by Year (None–None)
Century Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Century Therapeutics Inc. For the full cash flow conversion analysis, see IPSC cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.